In normal and premalignant epithelial cells, TGF-β1 generally suppresses tumor progression, but TGF-β pathway dysregulation under certain conditions leads to extensive signal reprogramming, which allows cancer cells to survive and successfully spread in other tissues [9,10]. Here, TGFB1 is linked to cancer.